83 related articles for article (PubMed ID: 7851812)
21. Changes in biochemical markers of osteoblastic activity during the menstrual cycle.
Nielsen HK; Brixen K; Bouillon R; Mosekilde L
J Clin Endocrinol Metab; 1990 May; 70(5):1431-7. PubMed ID: 2110577
[TBL] [Abstract][Full Text] [Related]
22. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.
Missmer SA; Spiegelman D; Bertone-Johnson ER; Barbieri RL; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):972-8. PubMed ID: 16702379
[TBL] [Abstract][Full Text] [Related]
23. Effect of the variations of female sex hormones during the menstrual cycle upon serum somatomedin and growth-promoting activity.
Guidoux S; Garnier PE; Schimpff RM
Horm Res; 1986; 23(1):31-7. PubMed ID: 3079724
[TBL] [Abstract][Full Text] [Related]
24. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause.
Pluchino N; Cubeddu A; Begliuomini S; Merlini S; Giannini A; Bucci F; Casarosa E; Luisi M; Cela V; Genazzani AR
Hum Reprod; 2009 Sep; 24(9):2303-9. PubMed ID: 19491202
[TBL] [Abstract][Full Text] [Related]
25. Modulation of plasma endothelin levels by the menstrual cycle.
Polderman KH; Stehouwer CD; van Kamp GJ; Schalkwijk CG; Gooren LJ
Metabolism; 2000 May; 49(5):648-50. PubMed ID: 10831177
[TBL] [Abstract][Full Text] [Related]
26. [Luteal and follicular phase inhibin A and B in regularly cycling women].
Jakimiuk AJ; Jezierska Z; Tarkowski R; Dziduch P; Tomaszewski J; Haczyński J; Jakowicki JA
Ginekol Pol; 2001 Dec; 72(12A):1393-7. PubMed ID: 11883285
[TBL] [Abstract][Full Text] [Related]
27. Substrate and hormonal responses to exercise in women using oral contraceptives.
Bonen A; Haynes FW; Graham TE
J Appl Physiol (1985); 1991 May; 70(5):1917-27. PubMed ID: 1864771
[TBL] [Abstract][Full Text] [Related]
28. GH responsiveness varies during the menstrual cycle.
Gleeson HK; Shalet SM
Eur J Endocrinol; 2005 Dec; 153(6):775-9. PubMed ID: 16322382
[TBL] [Abstract][Full Text] [Related]
29. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
Chaireti R; Gustafsson KM; Byström B; Bremme K; Lindahl TL
Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
[TBL] [Abstract][Full Text] [Related]
30. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells.
Yovel G; Shakhar K; Ben-Eliyahu S
Gynecol Oncol; 2001 May; 81(2):254-62. PubMed ID: 11330959
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptive therapy reduces serum relaxin-2 in elite female athletes.
Nose-Ogura S; Yoshino O; Yamada-Nomoto K; Nakamura M; Harada M; Dohi M; Okuwaki T; Osuga Y; Kawahara T; Saito S
J Obstet Gynaecol Res; 2017 Mar; 43(3):530-535. PubMed ID: 28026087
[TBL] [Abstract][Full Text] [Related]
32. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
Ovesen P; Vahl N; Fisker S; Veldhuis JD; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
[TBL] [Abstract][Full Text] [Related]
33. The circadian pattern of melatonin and its positive relationship with progesterone in women.
Webley GE; Leidenberger F
J Clin Endocrinol Metab; 1986 Aug; 63(2):323-8. PubMed ID: 3722324
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
Br J Cancer; 2005 Mar; 92(5):857-66. PubMed ID: 15756256
[TBL] [Abstract][Full Text] [Related]
35. Menstrual cycle and oral contraceptives' effects on growth hormone response to sprinting.
Sunderland C; Tunaley V; Horner F; Harmer D; Stokes KA
Appl Physiol Nutr Metab; 2011 Aug; 36(4):495-502. PubMed ID: 21848445
[TBL] [Abstract][Full Text] [Related]
36. Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle.
Barnett JB; Woods MN; Lamon-Fava S; Schaefer EJ; McNamara JR; Spiegelman D; Hertzmark E; Goldin B; Longcope C; Gorbach SL
J Clin Endocrinol Metab; 2004 Feb; 89(2):776-82. PubMed ID: 14764796
[TBL] [Abstract][Full Text] [Related]
37. [Influence of premenstrual syndrome and oral contraceptive effects on food choice during the follicular and luteal phase of the menstrual cycle].
Tucci SA; Murphy LE; Boyland EJ; Halford JC
Endocrinol Nutr; 2009 Apr; 56(4):170-5. PubMed ID: 19627733
[TBL] [Abstract][Full Text] [Related]
38. Plasma insulin and glucagon concentrations and biochemical variables in regularly menstruating females with ovulatory and anovulatory menstrual cycles.
Lutosławska G; Skierska E; Keska A; Byszewska-Szpocińska E
Horm Metab Res; 2003 Jul; 35(7):444-50. PubMed ID: 12931277
[TBL] [Abstract][Full Text] [Related]
39. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise.
Lynch NJ; Nimmo MA
Eur J Appl Physiol Occup Physiol; 1998 Nov; 78(6):565-72. PubMed ID: 9840414
[TBL] [Abstract][Full Text] [Related]
40. Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
Ahmed AH; Gordon RD; Ward G; Wolley M; Kogovsek C; Stowasser M
Clin Endocrinol (Oxf); 2015 Sep; 83(3):303-7. PubMed ID: 25523596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
